Sort
78,016 grants matching “breast cancer”
Pre-clinical evaluation of DT-001, a small molecule antagonist of MD2-TLR4 for utility in the treatment of pain.
$646,527Tony L Yaksh · Douleur Therapeutics, Inc. · R41 · FY2019 · NS
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
$646,527Aarti Asnani · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
$646,503Eric Jessen Chow · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
GigaFIBI; rapid, large-format histology-resolution imaging for Intraoperative assessment of breast lumpectomy margins
$646,467Farzad Fereidouni · University Of California At Davis · R01 · FY2023 · CA
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI
$646,456Univ Of Massachusetts Med Sch Worcester · N01 · FY2000 · WH
3D Photoacoustic Tomography (PAT)and Dynamic Contrast-Enhanced PAT Breast Imaging
$646,441Robert A Kruger · Optosonics, Inc. · R01 · FY2016 · CA
Accuracy of Breast Pathology and the Impact of Double Reading
$646,440Joann G Elmore · University Of Washington · R01 · FY2012 · CA
Advancing breast cancer risk prediction in national cohorts: the role of mammogram-based deep learning
$646,425Parisa Tehranifar · Columbia University Health Sciences · U01 · FY2025 · CA
Stimulation of Tumorigenesis by NKG2D
$646,415Thomas Spies · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Stimulation of Tumorigenesis by NKG2D
$646,415Thomas Spies · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Occupational Exposure Assessment
$646,414Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$646,356Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2024 · CA
MTA1 in Oncogenesis
$646,348Rakesh Kumar · George Washington University · R01 · FY2009 · CA
Use of advanced imaging techniques to improve diagnostic methods for ARDS
$646,344Ednan K. Bajwa · Massachusetts General Hospital · R01 · FY2014 · HL
Site-specific Integration of Large (10-100 kb) DNA Constructs into the Mouse Genome and Human Induced Pluripotent Stem Cells Using the Cas9-Bxb1 Integrase Toolbox
$646,321Vishnu Hosur · Jackson Laboratory · R01 · FY2022 · CA
Novel Monoclonal Antibody Therapy for Cancer
$646,303Galaxy Biotech, Llc · R44 · FY2005 · CA
Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors
$646,190Lisa Anne Cadmusbertram · University Of Wisconsin-Madison · R37 · FY2019 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$646,146Robert H Vonderheide · University Of Pennsylvania · P01 · FY2021 · CA
3-D modeling-based decision support for optimizing quality of life following breast reconstruction
$646,144Mia K Markey · University Of Texas At Austin · R01 · FY2019 · CA
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
$645,976David Eric Gerber · Ut Southwestern Medical Center · U10 · FY2016 · CA
Exploiting SAMHD1 in Directing Radiation and Immunologic Dynamics
$645,949David Sung-Wen Yu · Emory University · R01 · FY2025 · CA
THERAPEUTIC BENEFIT OF POTASSIUM CHANNEL ACTIVATORS IN TRIPLE-NEGATIVE BREAST CANCER
$645,861University Of Illinois · · FY2020 · Defense Health Agency
The role of IWS1 in development and tumorigenesis
$645,852Philip N Tsichlis · Ohio State University · R01 · FY2018 · CA
Characterizing the Risk of Chemotherapy Side Effects Based on Epigenetic Age and Modification by Resistance Training Intervention
$645,794Alexandra Margaret Lynn Binder · University Of Hawaii At Manoa · R37 · FY2022 · CA
Social networks and disparities in health behaviors and breast cancer outcomes in immigrant women
$645,782Candyce H Kroenke · Kaiser Foundation Research Institute · R01 · FY2020 · CA